1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Mrs V A Whyte
|
|
b)
|
Position/status
|
Company Secretary
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description of
the financial instrument
|
Ordinary shares of 25 pence each "Ordinary Shares"
ISIN: GB0009252882
|
|
b)
|
Nature
of the transaction
|
The
exercise of options over 4,820 Ordinary Shares, granted on 19
February 2008 under the GlaxoSmithKline 2001 Share Option Plan - UK
Unapproved Trust.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£11.47
|
4,820
|
||
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a (single transaction)
|
|
e)
|
Date
of the transaction
|
2017-06-20
|
|
f)
|
Place
of the transaction
|
n/a
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Mrs V A Whyte
|
|
b)
|
Position/status
|
Company Secretary
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description of
the financial instrument
|
Ordinary shares of 25 pence each "Ordinary Shares"
ISIN: GB0009252882
|
|
b)
|
Nature
of the transaction
|
The
sale of 4,820 Ordinary Shares following the exercise of options
granted on 19 February 2008 under the GlaxoSmithKline 2001 Share
Option Plan - UK Unapproved Trust.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£16.93
|
4,820
|
||
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a (single transaction)
|
|
e)
|
Date
of the transaction
|
2017-06-20
|
|
f)
|
Place
of the transaction
|
London Stock Exchange (XLON)
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: June
21, 2017
|
|
|
|
|
By: VICTORIA
WHYTE
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|